1.Surgical Repair in Case of an Elderly Tetralogy of Fallot
Yoshifumi Chida ; Fumio Yamamoto ; Hiroshi Yamamoto ; Kazuyuki Ishibashi ; Genbu Yamaura ; Keisuke Shiroto ; Mamika Motokawa ; Fuminobu Tanaka ; Keiji Seki ; Makoto Matsukawa
Japanese Journal of Cardiovascular Surgery 2010;39(3):133-136
A 62-year-old woman with the tetralogy of Fallot (TOF) diagnosed at 24 years of age, was admitted with fever and dyspnea. She also had cyanosis and heart failure and was categorized as New York Heart Association (NYHA) functional class IV. Echocardiography showed TOF with a-grade III tricuspid valve regurgitation. Cardiac catheterization revealed major aorto-pulmonary collateral arteries (MAPCAs) for the left upper pulmonary circulation. After coil embolization of MAPCAs to reduce abnormal intracardiac return as well as postoperative left ventricular volume overload, the patient underwent total surgical correction (i.e., right ventricular outflow tract reconstruction using Medtronic FreeStyle Valve and transannular patch, ventricular septal defect closure, and tricuspid annuloplasty). Postoperatively, the patient had a satisfactory course during the 10-year follow-up period with a grade-I NYHA classification. In conclusion, intracardiac repair of TOF in case over 60 years of age can be performed safely by preoperative MAPCAs embolization and subsequent TOF repair with a strategy to abolish pulmonary and tricuspid valve regurgitation.
2.The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Kaori YAMAMOTO-ISHIKAWA ; Hiroyoshi SUZUKI ; Masahiko NEZU ; Naoto KAMIYA ; Takashi IMAMOTO ; Akira KOMIYA ; Kazuyuki SOGAWA ; Takeshi TOMONAGA ; Fumio NOMURA ; Tomohiko ICHIKAWA
Asian Journal of Andrology 2009;11(3):299-307
Androgens play a central role in prostate cancer pathogenesis, and hence most of the patients respond to androgen deprivation therapies. However, patients tend to relapse with aggressive prostate cancer, which has been termed as hormone refractory. To identify the proteins that mediate progression to the hormone-refractory state, we used protein-chip technology for mass profiling of patients' sera. This study included 16 patients with metastatic hormone-refractory prostate cancer who were initially treated with androgen deprivation therapy. Serum samples were collected from each patient at five time points: point A, pre-treatment; point B, at the nadir of the prostate-specific antigen (PSA) level; point C, PSA failure; point D, the early hormone-refractory phase; and point E, the late hormone-refractory phase. Using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry, we performed protein mass profiling of the patients' sera and identified a 6 640-Da peak that increased with disease progression. Target proteins were partially purified, and by amino acid sequencing the peak was identified as a fragment of apolipoprotein C-I (ApoC-I). Serum ApoC-I protein levels increased with disease progression. On immunohistochemical analysis, the ApoC-I protein was found localized to the cytoplasm of the hormone-refractory cancer cells. In this study, we showed an increase in serum ApoC-I protein levels in prostate cancer patients during their progression to the hormone-refractory state, which suggests that ApoC-I protein is related to progression of prostate cancer. However, as the exact role of ApoC-I in prostate cancer pathogenesis is unclear, further research is required.
Aged
;
Amino Acid Sequence
;
Antineoplastic Agents, Hormonal
;
therapeutic use
;
Apolipoprotein C-I
;
analysis
;
blood
;
isolation & purification
;
Blotting, Western
;
Cell Line
;
Disease Progression
;
Drug Resistance, Neoplasm
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Molecular Sequence Data
;
Prognosis
;
Prostatic Neoplasms
;
drug therapy
;
metabolism
;
Protein Array Analysis
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
3.A “Back Light System” for Identification of Sites for Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Solid Pancreatic Masses: A Prospective, Randomized Study with a Crossover Design
Ryo HARADA ; Hironari KATO ; Soichiro FUSHIMI ; Hirofumi INOUE ; Daisuke UCHIDA ; Yutaka AKIMOTO ; Takeshi TOMODA ; Kazuyuki MATSUMOTO ; Yasuhiro NOMA ; Naoki YAMAMOTO ; Shigeru HORIGUCHI ; Koichiro TSUTSUMI ; Hiroyuki OKADA
Clinical Endoscopy 2019;52(4):334-339
BACKGROUND/AIMS: We applied a back light system (BLS) with a magnifying glass to improve the ability to assess the adequacy of specimen sampling using endosonography. We conducted this study to evaluate the efficacy of the BLS in sampling of specimens by endoscopic ultrasound-guided fine needle aspiration of solid pancreatic masses. METHODS: This was a prospective, randomized, crossover, single-center clinical trial. An endosonographer evaluated adequacy on gross visual inspection and identified whitish specimen sampling sites with and without the BLS according to a randomization sequence in the first and second passes with a 25-G needle. On cytological evaluation, the presence of well-defined pancreatic ductal epithelium was evaluated by a cytopathologist who was blinded to any clinical information. RESULTS: A total of 80 consecutive patients were eligible during the study period. Adequacy was observed for 52 specimens (65%) with the BLS and 54 (68%) without the BLS (p=0.88). In assessment of specimen adequacy on gross examination, only fair agreement was observed both with and without BLS (kappa score 0.40 and 0.29, respectively). CONCLUSIONS: The BLS did not influence the ability to identify specimen sampling sites or reliable assessment of specimen site adequacy using gross visual inspection.
Biopsy, Fine-Needle
;
Cross-Over Studies
;
Endoscopic Ultrasound-Guided Fine Needle Aspiration
;
Endosonography
;
Epithelium
;
Glass
;
Humans
;
Needles
;
Pancreatic Ducts
;
Pancreatic Neoplasms
;
Prospective Studies
;
Random Allocation
4.Effect of Patient Handouts on Use of the Family Pharmacist System —Comparison of Compliant and Non-Compliant Family Pharmacies—
Yuya URAGAMI ; Kanako BABA ; Kazuhiro TAKIKAWA ; Kengo MABUCHI ; Naoko NAGURA ; Kazuyuki YAMAMOTO ; Naomi IIHARA
Japanese Journal of Social Pharmacy 2022;41(2):149-154
Objective : Recently, a directive that all pharmacies should have a family pharmacist by 2025 was announced. However, this directive has not been clearly communicated to patients. The purpose of this study was to examine the effect of patient information handouts on the number of patients who use the new family pharmacist system, using the evaluation index of family pharmacies (Key Performance Indicator [KPI]). Methods : We created and distributed patient handouts about family pharmacists. The number of new family pharmacists, the number of consultations, and the consultation content from June-August 2021 (pre-distribution period) and September-November 2021 (distribution period) were examined to compare the KPI group and non-KPI group. A cutoff score of the KPI index was used to determine compliant vs. non-compliant. Results : The median (interquartile range) number of new patients in the KPI group (7 pharmacies) increased from 0 (0.0, 1.5) in the pre-distribution period to 4 (2.5, 10.5) in the distribution period (P=0.019). In the non-KPI group (4 pharmacies) it was 0 (0.0, 0.0) both before and after distribution. The number of consultations about unused prescribed medications and health increased (P=0.031 and 0.047, respectively) in the KPI group during the distribution period, with no change in the non-KPI group. Conclusion : The use of handouts led to an increase in users of the family pharmacist system in the KPI group. The use of handouts at KPI pharmacies will help patients understand the pharmacist profession and the benefits of the family pharmacist system.